Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia

5-Hydroxytryptamine type 2 antagonists are used to treat symptomatic peripheral arterial disease. However, it remains unknown as to whether the administration of sarpogrelate, a 5-hydroxytryptamine type 2 antagonist, improves the prognosis after endovascular therapy for critical limb ischemia (CLI)....

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Takahara, Mitsuyoshi, Kaneto, Hideaki, Katakami, Naoto, Iida, Osamu, Matsuoka, Taka-aki, Shimomura, Iichiro
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Japan 2013
Pynciau:
Short Communication
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4085500/
https://ncbi.nlm.nih.gov/pubmed/23494607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00380-013-0334-1
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg